Monthly Cost Comparison: Budgeting Your Treatment Journey
Mounjaro Wegovy Monthly Cost Structure Explained
Understanding the monthly costs of Mounjaro versus Wegovy requires examining both treatments' unique dose escalation schedules and maintenance pricing. Wegovy follows a structured 16-week escalation from 0.25mg (£79.99) to the 2.4mg maintenance dose (£209.99), whilst Mounjaro uses tirzepatide with its own escalation pathway. Both prescription-only medicines require clinical assessment and ongoing prescriber support throughout treatment. The monthly cost varies significantly during the initial months as doses increase, making budget planning essential for long-term success. EverydayMeds provides transparent pricing for both treatments, allowing patients to compare total monthly costs across their entire treatment journey.
The key difference in Mounjaro wegovy monthly costs lies in their active ingredients and dosing schedules. Wegovy contains semaglutide as a GLP-1 receptor agonist, while Mounjaro uses tirzepatide as a dual GIP and GLP-1 receptor agonist. This pharmaceutical difference impacts not only efficacy profiles but also manufacturing costs and resulting patient pricing. Both treatments are available through our GPhC-registered pharmacy (#9012878) with the same clinical assessment process and next-day delivery service. Patients can expect consistent monthly costs once reaching maintenance doses, typically after 16 weeks of gradual escalation.
Wegovy Pricing Structure: Complete Monthly Breakdown
Wegovy monthly costs at EverydayMeds follow a clear escalation pattern designed to optimise tolerability and effectiveness. Months 1-2 cost £79.99 for the 0.25mg starter dose, followed by £94.99 for 0.5mg in months 3-4, then £99.99 for 1mg in months 5-6, and £139.99 for 1.7mg in months 7-8. The maintenance dose of 2.4mg costs £209.99 monthly from month 9 onwards. New customers apply discount code FIRST40 at checkout, while returning customers use DOSE25 to access these prices. Our bundle options like the Intro Trio (£299.99 for three months) provide convenient supply continuity during escalation phases.
The annual cost estimate for Wegovy at maintenance dose totals approximately £2,520 based on the 2.4mg monthly price of £209.99. This calculation assumes patients reach and maintain the target dose without interruption, alongside their reduced-calorie diet and increased physical activity programme. Bundle pricing offers convenience rather than savings, with options like the Ultimate Stability Trio providing three months of 2.4mg supply for £649.99. Patients can budget more effectively knowing that monthly costs stabilise at the maintenance phase, with no hidden fees or additional charges beyond the pen cost.
Clinical Evidence Supporting Mounjaro Wegovy Investment
The STEP clinical trial programme demonstrates Wegovy's effectiveness in supporting weight management when used alongside lifestyle modifications. In STEP 1, patients taking Wegovy achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo, whilst STEP 3 showed around clinically studied weight loss with intensive behavioural therapy. The SELECT cardiovascular outcomes trial revealed a 20% reduction in major cardiovascular events, adding clinical value beyond weight management alone.
When evaluating Mounjaro wegovy monthly cost against clinical outcomes, both treatments show significant efficacy in their respective trial programmes. However, direct head-to-head comparisons aren't appropriate due to different trial designs, patient populations, and endpoints used in their clinical development. Both medicines work through appetite regulation and satiety enhancement, though Mounjaro's dual receptor mechanism differs from Wegovy's GLP-1-only approach. Patients should discuss their individual clinical profile with prescribers to determine which treatment offers optimal value for their specific circumstances.
How Wegovy Works to Justify Monthly Investment
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone GLP-1 produced in the intestines after eating. This mechanism reduces appetite by acting on brain centres that control hunger and satiety, helping patients feel fuller after smaller meals and reducing food cravings between meals. The once-weekly injection provides consistent appetite suppression throughout the week, supporting adherence to reduced-calorie diets more effectively than daily medications. Unlike appetite suppressants that work through stimulant mechanisms, Wegovy works through natural hormone pathways that regulate eating behaviour. The gradual dose escalation allows the body to adjust to these hormonal changes whilst minimising side effects and optimising long-term tolerability.
Streamlined Ordering Process for Both Treatments
Accessing Mounjaro or Wegovy through EverydayMeds begins with our 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Our prescribers review applications within 3 working days (express 24-hour service available), ensuring clinical appropriateness before dispensing either prescription-only medicine. Once approved, medications are dispatched via next-day delivery using temperature-controlled cold-chain logistics to maintain product integrity. The GPhC-registered pharmacy (#9012878) ensures all regulatory requirements are met whilst providing convenient online access to these specialist treatments. Patients receive comprehensive information about their chosen treatment, including injection technique guidance and lifestyle support resources.
Storage and Practical Considerations Affecting Value
Wegovy offers a practical storage advantage over Mounjaro, remaining stable at room temperature for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This flexibility particularly benefits patients who travel frequently or prefer not storing medications in shared refrigerators. The FlexTouch pen design provides consistent dose delivery with clear dose windows and audible click confirmation when injection is complete. Proper storage maintains medication potency throughout the month, ensuring patients receive full therapeutic benefit from their investment. Both treatments require initial refrigerated storage at 2-8°C before first use, with specific handling instructions provided with each delivery.
Long-term Cost Planning for Mounjaro Wegovy Treatment
Successful weight management requires long-term commitment, making monthly cost predictability essential for treatment adherence. The STEP 1 extension study showed patients regained approximately two-thirds of lost weight within one year of stopping Wegovy, emphasising the importance of sustained treatment for maintaining results. Monthly budgeting should account for the maintenance dose cost of £209.99, representing the ongoing investment required for continued weight management support. Patients can optimise their treatment investment by combining medication with comprehensive lifestyle modifications, maximising the value derived from their monthly expenditure.
Both Mounjaro and Wegovy represent significant monthly investments in health, requiring careful financial planning alongside clinical consideration. The decision between treatments should factor in not only monthly costs but also individual clinical response, tolerability, and lifestyle compatibility. EverydayMeds provides both options with identical service standards, allowing prescribers and patients to choose based purely on clinical and personal preference rather than access limitations.
Complete Treatment Access Through EverydayMeds
Both Wegovy and Mounjaro are available from EverydayMeds with transparent pricing, comprehensive clinical support, and reliable UK-wide delivery. New customers use discount code FIRST40 at checkout, whilst returning customers apply DOSE25 to access our competitive pricing structure. Our clinical team provides ongoing support throughout treatment, helping patients navigate dose escalations, manage side effects, and optimise their weight management journey. The monthly investment in either treatment includes access to our clinical helpline, educational resources, and prescription management services. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and start your weight management journey with confidence in both clinical and financial transparency.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
